Report Detail

Pharma & Healthcare Impact of COVID-19 Outbreak on EPA & DHA Omega-3, Global Market Research Report 2020

  • RnM3988496
  • |
  • 05 June, 2020
  • |
  • Global
  • |
  • 137 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the EPA & DHA Omega-3 market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the EPA & DHA Omega-3 industry.

Segment by Type, the EPA & DHA Omega-3 market is segmented into
Marine Animals Source Omega-3
Marine Plant Source Omega-3

Segment by Application
Dietary Supplements
Fortified Food and Beverage
Infant Formula
Pharmaceuticals
Pet Foods
Others

Global EPA & DHA Omega-3 Market: Regional Analysis
The EPA & DHA Omega-3 market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
The key regions covered in the EPA & DHA Omega-3 market report are:
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

Global EPA & DHA Omega-3 Market: Competitive Analysis
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global EPA & DHA Omega-3 market include:
DSM
BASF
EPAX
Golden Omega
TASA
Omega Protein
Croda
Marine Ingredients
GC Rieber
Polaris
Auqi
Kinomega
Skuny
Xinzhou
Anti-Cancer
Sinomega
Orkla Health
LYSI
OLVEA Fish Oils
Hofseth BioCare
Nippon Suisan Kaisha
KD Pharma
Shandong Yuwang Pharmaceutical
Maruha Nichiro Foods
Solutex
Bioprocess Algae


1 EPA & DHA Omega-3 Market Overview

  • 1.1 Product Overview and Scope of EPA & DHA Omega-3
  • 1.2 Covid-19 Impact on EPA & DHA Omega-3 Segment by Type
    • 1.2.1 Global EPA & DHA Omega-3 Sales Growth Rate Comparison by Type (2021-2026)
    • 1.2.2 Marine Animals Source Omega-3
    • 1.2.3 Marine Plant Source Omega-3
  • 1.3 Covid-19 Impact on EPA & DHA Omega-3 Segment by Application
    • 1.3.1 EPA & DHA Omega-3 Sales Comparison by Application: 2020 VS 2026
    • 1.3.2 Dietary Supplements
    • 1.3.3 Fortified Food and Beverage
    • 1.3.4 Infant Formula
    • 1.3.5 Pharmaceuticals
    • 1.3.6 Pet Foods
    • 1.3.7 Others
  • 1.4 Covid-19 Impact on Global EPA & DHA Omega-3 Market Size Estimates and Forecasts
    • 1.4.1 Global EPA & DHA Omega-3 Revenue 2015-2026
    • 1.4.2 Global EPA & DHA Omega-3 Sales 2015-2026
    • 1.4.3 EPA & DHA Omega-3 Market Size by Region: 2020 Versus 2026
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on EPA & DHA Omega-3 Industry
  • 1.7 COVID-19 Impact: EPA & DHA Omega-3 Market Trends

2 Covid-19 Impact on Global EPA & DHA Omega-3 Market Competition by Manufacturers

  • 2.1 Global EPA & DHA Omega-3 Sales Market Share by Manufacturers (2015-2020)
  • 2.2 Global EPA & DHA Omega-3 Revenue Share by Manufacturers (2015-2020)
  • 2.3 Global EPA & DHA Omega-3 Average Price by Manufacturers (2015-2020)
  • 2.4 Manufacturers EPA & DHA Omega-3 Manufacturing Sites, Area Served, Product Type
  • 2.5 EPA & DHA Omega-3 Market Competitive Situation and Trends
    • 2.5.1 EPA & DHA Omega-3 Market Concentration Rate
    • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
    • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
  • 2.7 Primary Interviews with Key EPA & DHA Omega-3 Players (Opinion Leaders)

3 Covid-19 Impact on EPA & DHA Omega-3 Retrospective Market Scenario by Region

  • 3.1 Global EPA & DHA Omega-3 Retrospective Market Scenario in Sales by Region: 2015-2020
  • 3.2 Global EPA & DHA Omega-3 Retrospective Market Scenario in Revenue by Region: 2015-2020
  • 3.3 North America EPA & DHA Omega-3 Market Facts & Figures by Country
    • 3.3.1 North America EPA & DHA Omega-3 Sales by Country
    • 3.3.2 North America EPA & DHA Omega-3 Sales by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe EPA & DHA Omega-3 Market Facts & Figures by Country
    • 3.4.1 Europe EPA & DHA Omega-3 Sales by Country
    • 3.4.2 Europe EPA & DHA Omega-3 Sales by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific EPA & DHA Omega-3 Market Facts & Figures by Region
    • 3.5.1 Asia Pacific EPA & DHA Omega-3 Sales by Region
    • 3.5.2 Asia Pacific EPA & DHA Omega-3 Sales by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America EPA & DHA Omega-3 Market Facts & Figures by Country
    • 3.6.1 Latin America EPA & DHA Omega-3 Sales by Country
    • 3.6.2 Latin America EPA & DHA Omega-3 Sales by Country
    • 3.6.3 Mexico
    • 3.6.3 Brazil
    • 3.6.3 Argentina
  • 3.7 Middle East and Africa EPA & DHA Omega-3 Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa EPA & DHA Omega-3 Sales by Country
    • 3.7.2 Middle East and Africa EPA & DHA Omega-3 Sales by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Covid-19 Impact on Global EPA & DHA Omega-3 Historic Market Analysis by Type

  • 4.1 Global EPA & DHA Omega-3 Sales Market Share by Type (2015-2020)
  • 4.2 Global EPA & DHA Omega-3 Revenue Market Share by Type (2015-2020)
  • 4.3 Global EPA & DHA Omega-3 Price Market Share by Type (2015-2020)
  • 4.4 Global EPA & DHA Omega-3 Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Covid-19 Impact on Global EPA & DHA Omega-3 Historic Market Analysis by Application

  • 5.1 Global EPA & DHA Omega-3 Sales Market Share by Application (2015-2020)
  • 5.2 Global EPA & DHA Omega-3 Revenue Market Share by Application (2015-2020)
  • 5.3 Global EPA & DHA Omega-3 Price by Application (2015-2020)

6 Company Profiles and Key Figures in EPA & DHA Omega-3 Business

  • 6.1 DSM
    • 6.1.1 Corporation Information
    • 6.1.2 DSM Description, Business Overview and Total Revenue
    • 6.1.3 DSM EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.1.4 DSM Products Offered
    • 6.1.5 DSM Recent Development and Response to COVID-19
  • 6.2 BASF
    • 6.2.1 BASF Corporation Information
    • 6.2.2 BASF Description, Business Overview and Total Revenue
    • 6.2.3 BASF EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.2.4 BASF Products Offered
    • 6.2.5 BASF Recent Development and Response to COVID-19
  • 6.3 EPAX
    • 6.3.1 EPAX Corporation Information
    • 6.3.2 EPAX Description, Business Overview and Total Revenue
    • 6.3.3 EPAX EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.3.4 EPAX Products Offered
    • 6.3.5 EPAX Recent Development and Response to COVID-19
  • 6.4 Golden Omega
    • 6.4.1 Golden Omega Corporation Information
    • 6.4.2 Golden Omega Description, Business Overview and Total Revenue
    • 6.4.3 Golden Omega EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 Golden Omega Products Offered
    • 6.4.5 Golden Omega Recent Development and Response to COVID-19
  • 6.5 TASA
    • 6.5.1 TASA Corporation Information
    • 6.5.2 TASA Description, Business Overview and Total Revenue
    • 6.5.3 TASA EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.5.4 TASA Products Offered
    • 6.5.5 TASA Recent Development and Response to COVID-19
  • 6.6 Omega Protein
    • 6.6.1 Omega Protein Corporation Information
    • 6.6.2 Omega Protein Description, Business Overview and Total Revenue
    • 6.6.3 Omega Protein EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.6.4 Omega Protein Products Offered
    • 6.6.5 Omega Protein Recent Development and Response to COVID-19
  • 6.7 Croda
    • 6.6.1 Croda Corporation Information
    • 6.6.2 Croda Description, Business Overview and Total Revenue
    • 6.6.3 Croda EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.4.4 Croda Products Offered
    • 6.7.5 Croda Recent Development and Response to COVID-19
  • 6.8 Marine Ingredients
    • 6.8.1 Marine Ingredients Corporation Information
    • 6.8.2 Marine Ingredients Description, Business Overview and Total Revenue
    • 6.8.3 Marine Ingredients EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.8.4 Marine Ingredients Products Offered
    • 6.8.5 Marine Ingredients Recent Development and Response to COVID-19
  • 6.9 GC Rieber
    • 6.9.1 GC Rieber Corporation Information
    • 6.9.2 GC Rieber Description, Business Overview and Total Revenue
    • 6.9.3 GC Rieber EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.9.4 GC Rieber Products Offered
    • 6.9.5 GC Rieber Recent Development and Response to COVID-19
  • 6.10 Polaris
    • 6.10.1 Polaris Corporation Information
    • 6.10.2 Polaris Description, Business Overview and Total Revenue
    • 6.10.3 Polaris EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.10.4 Polaris Products Offered
    • 6.10.5 Polaris Recent Development and Response to COVID-19
  • 6.11 Auqi
    • 6.11.1 Auqi Corporation Information
    • 6.11.2 Auqi EPA & DHA Omega-3 Description, Business Overview and Total Revenue
    • 6.11.3 Auqi EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.11.4 Auqi Products Offered
    • 6.11.5 Auqi Recent Development and Response to COVID-19
  • 6.12 Kinomega
    • 6.12.1 Kinomega Corporation Information
    • 6.12.2 Kinomega EPA & DHA Omega-3 Description, Business Overview and Total Revenue
    • 6.12.3 Kinomega EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.12.4 Kinomega Products Offered
    • 6.12.5 Kinomega Recent Development and Response to COVID-19
  • 6.13 Skuny
    • 6.13.1 Skuny Corporation Information
    • 6.13.2 Skuny EPA & DHA Omega-3 Description, Business Overview and Total Revenue
    • 6.13.3 Skuny EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.13.4 Skuny Products Offered
    • 6.13.5 Skuny Recent Development and Response to COVID-19
  • 6.14 Xinzhou
    • 6.14.1 Xinzhou Corporation Information
    • 6.14.2 Xinzhou EPA & DHA Omega-3 Description, Business Overview and Total Revenue
    • 6.14.3 Xinzhou EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.14.4 Xinzhou Products Offered
    • 6.14.5 Xinzhou Recent Development and Response to COVID-19
  • 6.15 Anti-Cancer
    • 6.15.1 Anti-Cancer Corporation Information
    • 6.15.2 Anti-Cancer EPA & DHA Omega-3 Description, Business Overview and Total Revenue
    • 6.15.3 Anti-Cancer EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.15.4 Anti-Cancer Products Offered
    • 6.15.5 Anti-Cancer Recent Development and Response to COVID-19
  • 6.16 Sinomega
    • 6.16.1 Sinomega Corporation Information
    • 6.16.2 Sinomega EPA & DHA Omega-3 Description, Business Overview and Total Revenue
    • 6.16.3 Sinomega EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.16.4 Sinomega Products Offered
    • 6.16.5 Sinomega Recent Development and Response to COVID-19
  • 6.17 Orkla Health
    • 6.17.1 Orkla Health Corporation Information
    • 6.17.2 Orkla Health EPA & DHA Omega-3 Description, Business Overview and Total Revenue
    • 6.17.3 Orkla Health EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.17.4 Orkla Health Products Offered
    • 6.17.5 Orkla Health Recent Development and Response to COVID-19
  • 6.18 LYSI
    • 6.18.1 LYSI Corporation Information
    • 6.18.2 LYSI EPA & DHA Omega-3 Description, Business Overview and Total Revenue
    • 6.18.3 LYSI EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.18.4 LYSI Products Offered
    • 6.18.5 LYSI Recent Development and Response to COVID-19
  • 6.19 OLVEA Fish Oils
    • 6.19.1 OLVEA Fish Oils Corporation Information
    • 6.19.2 OLVEA Fish Oils EPA & DHA Omega-3 Description, Business Overview and Total Revenue
    • 6.19.3 OLVEA Fish Oils EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.19.4 OLVEA Fish Oils Products Offered
    • 6.19.5 OLVEA Fish Oils Recent Development and Response to COVID-19
  • 6.20 Hofseth BioCare
    • 6.20.1 Hofseth BioCare Corporation Information
    • 6.20.2 Hofseth BioCare EPA & DHA Omega-3 Description, Business Overview and Total Revenue
    • 6.20.3 Hofseth BioCare EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.20.4 Hofseth BioCare Products Offered
    • 6.20.5 Hofseth BioCare Recent Development and Response to COVID-19
  • 6.21 Nippon Suisan Kaisha
    • 6.21.1 Nippon Suisan Kaisha Corporation Information
    • 6.21.2 Nippon Suisan Kaisha EPA & DHA Omega-3 Description, Business Overview and Total Revenue
    • 6.21.3 Nippon Suisan Kaisha EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.21.4 Nippon Suisan Kaisha Products Offered
    • 6.21.5 Nippon Suisan Kaisha Recent Development and Response to COVID-19
  • 6.22 KD Pharma
    • 6.22.1 KD Pharma Corporation Information
    • 6.22.2 KD Pharma EPA & DHA Omega-3 Description, Business Overview and Total Revenue
    • 6.22.3 KD Pharma EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.22.4 KD Pharma Products Offered
    • 6.22.5 KD Pharma Recent Development and Response to COVID-19
  • 6.23 Shandong Yuwang Pharmaceutical
    • 6.23.1 Shandong Yuwang Pharmaceutical Corporation Information
    • 6.23.2 Shandong Yuwang Pharmaceutical EPA & DHA Omega-3 Description, Business Overview and Total Revenue
    • 6.23.3 Shandong Yuwang Pharmaceutical EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.23.4 Shandong Yuwang Pharmaceutical Products Offered
    • 6.23.5 Shandong Yuwang Pharmaceutical Recent Development and Response to COVID-19
  • 6.24 Maruha Nichiro Foods
    • 6.24.1 Maruha Nichiro Foods Corporation Information
    • 6.24.2 Maruha Nichiro Foods EPA & DHA Omega-3 Description, Business Overview and Total Revenue
    • 6.24.3 Maruha Nichiro Foods EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.24.4 Maruha Nichiro Foods Products Offered
    • 6.24.5 Maruha Nichiro Foods Recent Development and Response to COVID-19
  • 6.25 Solutex
    • 6.25.1 Solutex Corporation Information
    • 6.25.2 Solutex EPA & DHA Omega-3 Description, Business Overview and Total Revenue
    • 6.25.3 Solutex EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.25.4 Solutex Products Offered
    • 6.25.5 Solutex Recent Development and Response to COVID-19
  • 6.26 Bioprocess Algae
    • 6.26.1 Bioprocess Algae Corporation Information
    • 6.26.2 Bioprocess Algae EPA & DHA Omega-3 Description, Business Overview and Total Revenue
    • 6.26.3 Bioprocess Algae EPA & DHA Omega-3 Sales, Revenue and Gross Margin (2015-2020)
    • 6.26.4 Bioprocess Algae Products Offered
    • 6.26.5 Bioprocess Algae Recent Development and Response to COVID-19

7 EPA & DHA Omega-3 Manufacturing Cost Analysis

  • 7.1 EPA & DHA Omega-3 Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Raw Materials Price Trend
    • 7.1.3 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of EPA & DHA Omega-3
  • 7.4 EPA & DHA Omega-3 Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 EPA & DHA Omega-3 Distributors List
  • 8.3 EPA & DHA Omega-3 Customers

9 Market Dynamics

  • 9.1 Market Trends
  • 9.2 Opportunities and Drivers
  • 9.3 Challenges
  • 9.4 Porter's Five Forces Analysis

10 Global Market Forecast

  • 10.1 Global EPA & DHA Omega-3 Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of EPA & DHA Omega-3 by Type (2021-2026)
    • 10.1.2 Global Forecasted Revenue of EPA & DHA Omega-3 by Type (2021-2026)
  • 10.2 EPA & DHA Omega-3 Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of EPA & DHA Omega-3 by Application (2021-2026)
    • 10.2.2 Global Forecasted Revenue of EPA & DHA Omega-3 by Application (2021-2026)
  • 10.3 EPA & DHA Omega-3 Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of EPA & DHA Omega-3 by Region (2021-2026)
    • 10.3.2 Global Forecasted Revenue of EPA & DHA Omega-3 by Region (2021-2026)
  • 10.4 North America EPA & DHA Omega-3 Estimates and Projections (2021-2026)
  • 10.5 Europe EPA & DHA Omega-3 Estimates and Projections (2021-2026)
  • 10.6 Asia Pacific EPA & DHA Omega-3 Estimates and Projections (2021-2026)
  • 10.7 Latin America EPA & DHA Omega-3 Estimates and Projections (2021-2026)
  • 10.8 Middle East and Africa EPA & DHA Omega-3 Estimates and Projections (2021-2026)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    Summary:
    Get latest Market Research Reports on Impact of COVID-19 Outbreak on EPA & DHA Omega-3. Industry analysis & Market Report on Impact of COVID-19 Outbreak on EPA & DHA Omega-3 is a syndicated market report, published as Impact of COVID-19 Outbreak on EPA & DHA Omega-3, Global Market Research Report 2020. It is complete Research Study and Industry Analysis of Impact of COVID-19 Outbreak on EPA & DHA Omega-3 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,285.20
    3,427.80
    4,570.40
    2,668.00
    4,002.00
    5,336.00
    451,240.00
    676,860.00
    902,480.00
    241,802.00
    362,703.00
    483,604.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report